29 results on '"Arhin, Francis"'
Search Results
2. Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019
3. 13: IN VITRO ACTIVITY OF CEFTAZIDIME-AVIBACTAM AND AZTREONAM-AVIBACTAM AGAINST CARBAPENEM-NONSUSCEPTIBLE ENTEROBACTERALES ISOLATES COLLECTED IN ASIA/PACIFIC FROM 2017–2020 AS PART OF THE ATLAS GLOBAL SURVEILLANCE PROGRAm
4. 11: IN VITRO ACTIVITY OF AZTREONAM-AVIBACTAM AGAINST ENTEROBACTERALES ISOLATES THAT CARRY METALLO-β-LACTAMASES COLLECTED IN THE ASIA/PACIFIC REGIONAS A PART OF THE ATLAS GLOBAL SURVEILLANCE PROGRAM FROM 2015–2020
5. In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019
6. Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012–2017
7. Supplier sustainability performance evaluation and selection: A framework and methodology
8. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci
9. Agar dilution minimum inhibitory concentrations under-represent oritavancin in vitro activity against staphylococci and enterococci
10. Assessment of the potential for oritavancin MIC changes among Staphylococcus aureus nasal carriage isolates following systemic oritavancin treatment in a phase 2 study in patients with acute bacterial skin and skin-structure infections
11. In vitro activity of Oritavancin against gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2015
12. Comparative in vitro activity of oritavancin and other agents against methicillin-susceptible and methicillin-resistant Staphylococcus aureus
13. Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus
14. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011–2014
15. In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene
16. Oritavancin retains bactericidal activity in vitro against standard and high inocula of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)
17. Correlation between oritavancin and vancomycin minimum inhibitory concentrations in staphylococci
18. Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus
19. Longitudinal analysis of the in vitro activity profile of oritavancin and comparator glycopeptides against Gram-positive organisms from Europe: 2005–2008
20. Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis
21. Comparative in vitro activity of oritavancin against recent, genetically diverse, community-associated meticillin-resistant Staphylococcus aureus (MRSA) isolates
22. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital
23. Time–kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes
24. Impact of human serum albumin on oritavancin in vitro activity against Staphylococcus aureus
25. Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis
26. Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters
27. A new class of small molecule RNA polymerase inhibitors with activity against Rifampicin-resistant Staphylococcus aureus1
28. Porins of Haemophilus influenzae Type b Mutated in Loop 3 and in Loop 4
29. Organization of the genes encoding p-aminobenzoic acid synthetase from Streptomyces lividans 1326
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.